NCT02395029View on ClinicalTrials.gov

Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

March 31, 2015

Conditions
Peyronie's Disease
Interventions
BIOLOGICAL

Placental Matrix-Derived Mesenchymal Stem Cells (PMD-MSCs)

Trial Locations (1)

33076

Z Urology, Coral Springs

All Listed Sponsors
lead

Melissa Marchand

OTHER

NCT02395029 - Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD | Biotech Hunter | Biotech Hunter